Poster Abstracts • OFID 2018:5 (Suppl 1) • S455 excluded. We also excluded patients with a present on admission secondary diagnosis of cholecystitis, appendicitis, peritonitis or abdominal infections.
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Results. Eighty patients with HAP were identified. Overall, 22/80 (27.5%) had therapy de-escalated and 47/80 (58.8%) continued empirical treatment. A total of 58 patients survived and were included in the analysis, 20 in de-escalation and 38 in continued empirical treatment. Length of stay was shorter in de-escalation by −7.2 (95% CI −12.2, −3.0) days, P < 0.01, with an adjusted difference of −3.2 (95% CI −8.3, 1.9) days, P = 0.21. The duration of treatment was shorter in de-escalation by −3.4 (95% CI −5.8, −0.9) days, P < 0.01, with an adjusted difference of −2.6 (95% CI −5.2, 0.1) days, P = 0.06. The cost of hospital stay was lower in de-escalation by £-2, 907.37 (95% CI −4,865.31, −949.43), P < 0.01, with an adjusted difference of £-1,290.00 (95% CI −3,320.75, 740.74), P = 0.21.
Conclusion. In HAP, 27.5% of patients were de-escalated. There was no difference in LOS, duration of treatment, and cost of hospital stay between de-escalation and continued empirical treatment on adjustment for confounders. Future work should explore the relationship between de-escalation and antimicrobial resistance in HAP.
Disclosures. All authors: No reported disclosures. Background. Granulomatous inflammation of the lung may be due to mycobacterial or fungal infections, sarcoidosis or vasculitis. When lung biopsy is performed due to suspicion of neoplasm, cultures may not always be done. In these cases, it is often not possible to order microbiologic testing when the pathology report is completed. The purpose of this study was to investigate how often patients with pulmonary nodules, who underwent biopsy for suspected malignancy, simultaneously have specimens sent for culture to assess for an infectious etiology.
Etiology of Pulmonary Granulomas: How Common is
Methods. We retrospectively reviewed the pathology reports of 36 patients from 2014 to 2015 who underwent lung biopsy of pulmonary nodules that showed granulomatous inflammation.
Results. Thirty-six patients underwent lung biopsy of pulmonary nodules. One patient was excluded because their pathology report did not reveal any granuloma, resulting in a final sample size of 35 patients. Of these, eight (22.9%) patients simultaneously had specimens sent for mycobacterial and fungal cultures while the other 27 (77.1%) did not. Of the 27 patients who did not have specimens simultaneously sent for mycobacterial and fungal cultures, 17 (48.6% of the sample size) were diagnosed with lung cancer. The remaining 10 (28.6% of the sample size) patients did not have a definitive diagnosis because cultures were not sent for testing (Figure 1) . Of the eight patients with cultures sent for testing, two (25%) had pulmonary tuberculosis, four (50%) had nontuberculosis mycobacterium infections, and two (25%) had fungal infections (one was Cryptococcus and one had mixed Aspergillus and Penicillium) (Figure 2) .
Conclusion. We conclude that pulmonary nodules may have an infectious etiology when biopsy is performed for a suspected malignancy. Specimens should routinely be sent for mycobacterial and fungal cultures regardless of presumptive diagnosis. 
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